810158C

Avanti

16:0 Liss Rhod PE

1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt), chloroform

Empirical Formula (Hill Notation):
C64H105N4O14PS2
CAS号:
分子量:
1249.64
NACRES:
NA.25
价格与库存信息目前不能提供

assay

>99% (TLC)

packaging

pkg of 1 × 1 mL (810158C-1mg)
pkg of 5 × 1 mL (810158C-5mg)

mfr. no.

Avanti Polar Lipids, 810158C

concentration

1 mg/mL (810158C-1mg)
1 mg/mL (810158C-5mg)

shipped in

dry ice

storage temp.

−20°C

General description

16:0 Liss Rhod PE is a fluorescent phospholipid.

Application

16:0 Liss Rhod PE has been used in the preparation of lipid-oil mixtures for fluorescent imaging and as a tracer lipid in process of unilamellar vesicles production. It is also suitable for fluorescent visualization of the phospholipids in tribiological investigation.

Packaging

5 mL Amber Glass Screw Cap Vial (810158C-5mg)
5 mL Amber Glass Screw Cap Vial (810158C-1mg)

Pictograms

Skull and crossbonesHealth hazard

Signal Word

Danger

Target Organs

Central nervous system

RIDADR

UN 1888 6.1 / PGIII

WGK Germany

WGK 3

Flash Point(F)

does not flash

Flash Point(C)

does not flash

分析证书
原产地证书 (CofO)
Tribological Analysis of UHMWPE Tibial Implants in Unicompartmental Knee Replacements: From Retrieved to In Vitro Studies
Sava MM, et al.
BioTechnology: An Indian Journal, 13, 1-15 (2018)
Three dimensional (temperature-tension-composition) phase map of mixed DOPC-DPPC vesicles: Two solid phases and a fluid phase coexist on three intersecting planes
Chen D, et al.
Biochimica et Biophysica Acta - Biomembranes, 1838(11), 2788-2797 (2014)
Hamed Hamedinasab et al.
International journal of biological macromolecules (2019-11-27)
The purpose of the present investigation was to formulate NAC (N-acetylcysteine)-loaded chitosan (CH)-coated liposome aiming at obtaining an effective formulation able to ensure a prolonged and controlled release of NAC to the lung by inhalation. Empty liposomes [(DPPG/Chol/DPPG with different...
Madi El-Haj et al.
Immunologic research, 67(4-5), 337-347 (2019-11-23)
The considerable variability of responses amongst subjects to disease triggers and immunotherapies is a major obstacle to designing better immune-based therapies. Therefore, development of patient-tailored precision medicine that improves the efficacy of immunomodulatory drugs is necessary. The individualized response to...
Dynamic morphologies of microscale droplet interface bilayers
Mruetusatorn P, et al.
Soft Matter, 10(15), 2530-2538 (2014)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。